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ABSTRACT 
POTENTIAL ROLE OF ATP8A1 AS PLASMA MEMBRANE 
AMINOPHOSPHOLIPID TRANSLOCASE IN PROLIFERATING NEURONAL 
CELLS 
by 
Kelly Levano 
 
Advisor: Professor Probal Banerjee 
The inner leaflet-localized phospholipid PS undergoes a translocation to the outer leaflet 
of the plasma membrane in apoptotic cells to trigger recognition and phagocytic removal 
of these dying cells by PS receptor-bearing scavenger cells, such as microglia and 
macrophages.  The enzyme activity responsible for the inner-membrane localization of 
PS is the plasma membrane aminophospholipid translocase (PLAPLT), also known as 
flippase, which translocates PS from the outer to the inner leaflet of the plasma 
membrane.  Attempts to identify the PLAPLT molecule of mammalian cells have 
revealed a candidate molecule, Atp8a1, which is a P-type Mg-ATPase. After much 
controversy, it is currently believed that Atp8a1 translocates PS across internal 
membranes but not the plasma membrane.  Based on our earlier studies showing 
overexpression of Atp8a1 in proliferating hybrid neuroblastoma cells causes an increase 
PLAPLT activity, we postulated that Atp8a1 functions as PLAPLT only in fast dividing 
cells, such as neurotumor cells or neuroblasts.  This study used the fluorescent PS 
analogue, NBD-PS, to show that ectopic expression of Atp8a1 in the N18 neurotumor 
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Vmax for this enzyme, which suggests that overexpression of Atp8a1 causes an increase 
in the PLAPLT molecules.  This indicates that Atp8a1 is possibly identical to the 
PLAPLT molecule of the N18 cells. As a confirmation of this hypothesis we expressed 
phosphorylation-site mutants of Atp8a1 in the N18 cells to elicit a decrease in the Vmax 
value of PLAPLT, without significantly altering the Km value. The inhibition of the 
PLAPLT activity in N18 cells was also evidenced by a striking increase in surface 
staining of these cells with the PS-binding protein annexin V.  According to our postulate 
Atp8a1 deletion should also cause PS exposure in neuroblasts harbored within the dentate 
gyrus (DG), which is a proliferative niche within the memory center termed 
hippocampus.   In corroboration, we observed pronounced annexin V staining in both 
dissociated DG cells as well as cultured hippocampal slices of Atp8a1 (-/-) mice but not 
wild type mice.  Such PS externalization should trigger phagocytosis of DG cells, which 
in turn could lead to a loss of hippocampal function.  In support of this postulate we have 
observed that the Atp8a1 (-/-) mice suffer from possibly hippocampal-related learning 
defects. Therefore, Atp8a1 may play a crucial role in the maintenance of the functional 
integrity of the hippocampus.  Additionally, our study reveals a potential strategy for the 
selective removal of the brain tumor cells through targeted suppression of Atp8a1 activity 
in brain cancer cells, which would lead to PS externalization and elimination of the cells 
by phagocytosis. 
 vi 
 
 
 
 
 
 
 
 
 
 
 
 
 
I dedicate this thesis with love to Mami and Papi for all they have done to give me an 
education and a better life. You both made it possible for me to complete my thesis and 
come this far in life.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
ACKNOWLEDGEMENTS 
 
 
           This thesis could not be brought to a thesis stopping point without the efforts of 
hardworking and dedicated people. I would like to thank all the members of the 
Biochemistry doctoral program at the City University of New York Graduate Center for 
all their support. Also, I would like to thank the Alliance for Graduate Education and the 
Professoriate (AGEP) program, the Louis Stokes Alliance for Minority Participation (LS-
AMP) program of the City University of New York, and the National Institute of Health 
(NIH) minority supplement for supporting this project. A very special thanks to my 
mentor Dr. Probal Banerjee without whose support, encouragement and guidance the 
completion of this project could not have been possible. Also, I offer my sincere gratitude 
to the members of the supervisory committee for their guidance and advise. I would also 
like to thank the Project Administrator of the LS-AMP program Dr. Brathwaite and the 
Director of the Collegiate Science and Technology Entry Program (C-STEP) from the 
College of Staten Island Ms. Evans-Greene for their encouragement and support 
throughout my graduate studies. Special thanks also to all the members of Dr. Banerjee’s 
lab, especially to my very good friend Sudarshana from whom I have learned and 
continue to learn. Also, very special thanks to my friends and lab partners Priya, Shawn, 
Amit and Jason for all their support. Last but not least, I want to thank my best friend 
Buddi for all his support throughout these five years.  
           Finally, I would like to thank my parents who have demonstrated their own loving 
patience with their still-growing daughter through the years. I would also like to thank 
my loving grandmother, without her I will not be the person I am today.  
 viii 
Table of Contents 
 
Title Page……………………………………………………………………………….....i 
Copyright Page……………………………………………………………………….......ii 
Approval Page……………………………………………………………………….…..iii 
Abstract………………………………………………………………………………......iv 
Acknowledgements………………………………………………………………..........vii 
Table of Contents…………………………………………………………………........viii 
List of Tables and Figures…………………………………………………………….....x 
Abbreviations……………………………………………………………………….….xiv 
 
Chapter 1…………………………………………………………………………………1 
Introduction:…………………………………………………………………………..1 
1.1 Apoptosis and Phagocytosis……………………………………………........1 
1.2 Phosphatidylserine and plasma membrane asymmetry…………………..3 
1.3 Aminophospholipid Translocase activity and P-type ATPases…………...5 
1.4 Atp8a1………………………………………………………………………...7 
OBJECTIVE OF THIS STUDY………………………………………………...8 
Chapter 2………………………………………………………………………………..16 
Materials and Methods:……………………………………………………………..16 
2.1  Reagents…………………………………………………………………….16 
2.2  Animals……………………………………………………………………..17 
2.3  Cell lines…………………………………………………………………….17 
 ix 
2.4  Atp8a1 and Atp8a2 expression vectors…………………………………..17 
2.5  Phosphorylation-site mutant construct of Atp8a1……………………….18 
2.6  Transfection of cells with plasmid DNA………………………………….19 
2.7  Aminophospholipid translocase assay……………………………………20 
2.8  Membrane isolation using the Mem-PER kit…………………………….23 
2.9  SDS-PAGE and Immunoblotting analysis………………………………..23 
2.10 Annexin V staining………………………………………………………..24 
2.11 Genotyping to identify Atp8a1 (-/-) pups………………………………..25 
2.12 Dissociation of DG cells…………………………………………………...26 
2.13 Organotypic culture of hippocampal slices……………………………...26 
2.14 Evaluation of hippocampal function of the Atp8a1 (-/-) mice……….....27 
Chapter 3………………………………………………………………………………..32 
     Results:……………………………………………………………………………….32 
3.1 NBD-phosphatidylserine translocation from the outer to  
      inner leaflet of the plasma membrane of neuroblastoma cell line N18….32 
3.2 Overexpression of Atp8a1 causes an increase in the plasma 
      membrane APLT activity of the neuroblastoma cell line N18,  
      but not of differentiated HN2 cells………………………………………...37 
3.3 Transient overexpression of Atp8a1 in N18 cells causes an increase  
      in Vmax and no change in Km for the plasma membrane APLT……….41 
3.4 Transient expression of Atp8a1 phosphorylation-site mutants in N18 
      cells causes a decrease in the Vmax value without affecting the Km  
      value for the plasma membrane APLT……………………………………47 
 x 
 
3.5 Expression of phosphorylation-site mutants of Atp8a1 in N18  
      cells leads to PS externalization……………………………………………52  
3.6 Transient overexpression of Atp8a2 causes a decrease in both  
      Km and Vmax values of the plasma membrane APLT in  
      the mouse neuroblastoma cell line N18……………………………………56 
3.7 PS externalization in the Dentate Gyrus of Atp8a1 (-/-) mice…………...60 
Chapter 4………………………………………………………………………………..67 
     Discussion:…………………………………………………………………………...67 
References:………………………………………………………………………………76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
List of Tables and Figures 
 
Number             Page   
 
Figure 1      P-type ATPases ion-translocation cycle……...…………………………...9-10 
Figure 2      Phylogenetic analysis of the human and yeast Saccharomyces  
                    cerevisiae (in bold) type 4 ATPases…………………………………...……11 
Figure 3      Amino acid sequence alignment between Atp8a1 (accession  
                    number NM_009727) and Atp8a2 (accession number AF156550) 
                    shows a 67% sequence identity between the two type-IV P-type          
                    ATPases…………………………………………………………......…..12-15 
Figure 4      Fragment of the amino acid and cDNA sequences of the Mus  
                    musculus Atp8a1……………………………………………………………18 
Table 1       Primers……………………………………………………..………..............29 
Figure 5      Our modified aminophospholipid translocase (APLT) assay…….…….......30 
Figure 6      Conversion of the fluorescence values to µM/volume of outer  
                    leaflet of plasma membrane……………………..……………………….....31 
Figure 7      Reduction of NBD-PS (1-Oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol- 
                    4-yl)amino]hexanoyl]-sn-Glycero-3-Phospho-L-Serine) to ABD-PS 1- 
                    Oleoyl-2-[6-[(7-amino-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]- 
                    sn-Glycero-3-Phospho-L-Serine by sodium dithionite……………………..34 
Figure 8      Time-dependent translocation of NBD-PS from outer to inner  
                    leaflet of the plasma membrane of N18 cells…………………………...35-36 
 
Figure 9      Overexpression of Atp8a1 causes an increase in the plasma  
 xii 
                    membrane APLT of N18 cells, but not of HN2………………………..39-40 
Figure 10     Transient overexpression of Atp8a1 in the mouse  
                    neuroblastoma cell line N18 causes an increase in Vmax 
                    without any change in Km…………………..…………………………..44-45 
Table 2       Atp8a1 overexpression causes an increase in Vmax value  
                    of the APLT activity of the plasma membrane of N18 cells……………….46 
Figure 11     Transient expression of the Atp8a1-D409K phosphorylation 
                    site mutants causes an inhibition of Vmax without any significant  
                    change in Km for the APLT activity in the N18 cells…………………..49-50 
Table 3       Atp8a1-D409K expression causes a decrease in Vmax  
                    value of the APLT activity of the plasma membrane of N18 cells…………51 
Figure 12     Transient expression of Atp8a1 mutants causes externalization 
                    of PS in the N18 cells…………………………………………………...53-55 
Figure 13     Unlike Atp8a1, Atp8a2 causes a decrease in Vmax and  
                    Km for NBD-PS translocation in N18 cells……………………………57-58 
Table 4       Atp8a2 overexpression causes a decrease in Vmax value  
                    of the APLT activity of the plasma membrane of N18 cells………………59 
Figure 14     PS-externalization in cells from the dentate gyrus of  
                    Atp8a1 (-/-) mice but not of wild type mice…………………………….62-64 
Figure 15     PS externalization observed in the DG of the Atp8a1 (-/-) 
                    mice, but not the wild type mice……………………………………………65 
 
Figure 16     Atp8a1 (-/-) mice display a marked delay in  
 xiii 
                    hippocampal-dependent learning………………………………………...…66 
Figure 17     Proposed pathways by which PS is externalized during apoptosis………...75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv 
ABBREVIATIONS 
 
ABC                ATP-binding cassette 
ABD                7-amino-2,1,3-benzoxadiazol-4-yl 
Apaf-1             apoptotic protease activating factor-1  
DISC               death-inducing signaling complex 
DMEM           Dulbecco's Modified Eagles Medium 
FADD             Fas-associated death domain  
FBS                 fetal bovine serum  
GAS6              growth arrest-specific gene 6 
ICAM3            intercellular adhesion molecule-3 
LPC                 lysophosphatidylcholine 
mGBSS           modified Gey's balanced salt solution 
NBD-PS          1-Oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]- 
                        sn-Glycero-3-Phospho-L-Serine 
PC                    phosphatidylcholine 
PE                    phosphatidylethanolamine  
PM-APLT        Plasma Membrane Aminophospholipid Translocase 
PMSF              phenylmethylsulfonyl fluoride 
PS                    phosphatidylserine 
SM                   sphingomylein 
TRAIL            Tumor necrosis factor (TNF)-related apoptosis-inducing ligand  
 1 
CHAPTER 1 
INTRODUCTION 
 
1.1 Apoptosis and Phagocytosis: 
           Apoptosis, the most extensively studied form of cell death, is crucial to the 
homeostatic regulation and survival of multicellular organisms. Apoptosis occurs during 
development, such as in the homeostatic turnover of cells in various tissues, “during 
infections and wound healing, and disease states” (Ravichandran 2007).  Apoptosis can 
be divided into two primary phases: the signaling phase (caspase activation, DNA 
fragmentation and cell shrinkage) and the cell removal phase. The latter is a crucial event 
that prevents rupture of dying cells, activation of the immune response, and proliferation 
of unwanted cells.  
           The signaling phase of apoptosis can be divided into two pathways: extrinsic and 
intrinsic. In the extrinsic pathway, apoptosis is initiated through the activation of the 
death receptors or proapoptotic receptors: Fas, tumor necrosis factor, and TRAIL (tumor 
necrosis factor (TNF)-related apoptosis-inducing ligand). This is followed by the 
clustering and recruitment of adapter protein Fas-associated death domain (FADD) and 
procaspases 8 or 10 forming a death-inducing signaling complex (DISC) (Wang 2001, 
Kischkel 1995, Chinnaiyan 1995) leading to the activation of downstream caspases 3, 6, 
and/or 7. On the other hand, the intrinsic pathway is initiated by cellular signals resulting 
from hypoxia, defective cell cycle, DNA damage, or other cell stresses. In this pathway, 
pro-apoptotic proteins increase the permeability of the mitochondrial membrane leading 
to the release of cytochrome c. The pro-apoptotic proteins are members of the Bcl-2 
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superfamily of proteins, which are divided into two groups: those with a BH3 domain 
(Bid, Bad, Bim, Bmf, PUMA, and NOXA), and those with several BH domains (Bax and 
Bak) (Coultas 2003, Ashkenazi 2008). Released cytochrome c together with the adaptor 
apoptotic protease activating factor-1 (Apaf-1) and procaspase 9 form the apoptosome, a 
multiprotein complex that activates caspases 3, 6, and/ or 7 (Bao 2007, Henry-Mowatt 
2004). Both, extrinsic and intrinsic pathways, lead to the activation of caspases 3, 6 
and/or 7, the executionists of apoptotic signals inside the cell. They destroy essential 
cellular proteins, leading to controlled cell death.  
           The efficiency of the cell removal phase by the process of phagocytosis is crucial 
for “protecting tissue from harmful exposure to the inflammatory and immunogenic 
contents of dying cells” (Maderna 2003). Phagocytosis was first described by the Russian 
biologist Ilya Metchnikoff in the late 19th century (Krysko 2006). Professional 
phagocytes (monocytes, macrophages, dendritic cells, and mast cells) and 
nonprofessional phagocytes (hepatocytes, endothelial cells, epithelial cells, glomerular 
mesangial cells, and fibroblasts) (Hart 2008) mediate the apoptotic cell clearance phase, 
which can be divided into three steps: sensing and recognition of the apoptotic cell, 
engulfment and degradation, and the post-engulfment response of the phagocyte 
(Ravichandran 2007). It is known that degradation of apoptotic cells occurs rapidly; 
hence it is evident that necessary signals must be released at the early stages of apoptosis 
to bring phagocytes to close proximity of the apoptotic cell. Such signals termed ‘FIND-
ME’ signals, include LPC (lysophosphatidylcholine) identified by Lauber et al., and 
nucleotides (ATP and UTP) (Ravichandran 2007). The exact mechanism by which the 
signals are released and how they diffuse to attract phagocytes still remains elusive. Upon 
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attracting phagocytes, apoptotic cells undergo changes to produce recognition signals, 
these “EAT-ME” signals, which “are displayed on the surface of dying cells very early in 
the apoptotic process” (Ravichandran 2007),  include externalization of 
phosphatidylserine (PS) in the outer layer of the plasma membrane, glycosylation 
(addition of sugars such as galactose, mannose, and N-glucosamine) of proteins and 
lipids, binding of thrombospondin to sulfated glycolipids, and expression of ICAM3 
(intercellular adhesion molecule-3) and oxidized LDL-like moiety (Ravichandran 2007, 
Kerr 1972, Fadok 1999) .   
 
1.2 Phosphatidylserine and plasma membrane asymmetry: 
           Phosphatidylserine (PS) exposure is the best-studied ‘EAT-ME’ signal. PS, which 
is normally present in the inner leaflet of the plasma membrane, reorients to the outer 
leaflet (Martin 1995, Fadok 1992) where it is recognized “as a naked lipid or in 
combination with” bridging molecules by phagocyte receptors. These bridging molecules 
include growth arrest-specific gene 6 (GAS6) and protein S (Ravichandran 2007, 
Anderson 2003, Nagata 1996).  
           The asymmetrical distribution of phospholipids in the plasma membrane has been 
extensively studied. As mentioned above, phosphatidylserine and 
phosphatidylethanolamine (PE) are mainly located in the cytosolic leaflet, while 
phosphatidylcholine (PC), sphingomylein (SM) and glycosphingolipids, reside in the 
outer leaflet (Ikeda 2006).  This distribution is possible because phospholipids are 
practically unable to flip-flop through the hydrophobic membrane interior due to their 
polar headgroups.  Consequently, such phospholipid translocation across the lipid bilayer 
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is a slow process requiring several hours to days (Lenoir 2007, Devaux 1992). 
Nonetheless, a protein or proteins or ‘flippases’ as described by Mark Bretscher in 1972, 
powers the unfavorable translocation or migration of phospholipids to maintain their 
asymmetry in the plasma membrane.  
           As mentioned earlier, during apoptosis, the asymmetry of the membrane gets 
compromised, bringing PS to the outer leaflet and exposing it to phagocytic cells. The 
exact mechanism that causes PS externalization is still unknown. Currently there are 
three proposed mechanisms by which PS-exposure can be regulated in the plasma 
membrane. These mechanisms include the three families of enzymes that maintain the 
asymmetric distribution of phospholipids: scramblases, floppases and flippases. 
Scramblases that are activated by Ca2+ play an important role in platelet activation and 
apoptosis. Rather than assisting, scramblases disrupt membrane asymmetry by ATP-
independent bidirectional transportation of phospholipids across the membrane. The loss 
of plasma membrane asymmetry causes PS externalization, which has been shown to 
cause activation of blood clotting factors and recognition of macrophage (Pomorski 2001, 
Daleke 2003). 
The other family of translocases, floppases, conducts an outward ATP-dependent 
translocation of phospholipids. These include the ABC (ATP-binding cassette) 
transporter family. There are conflicting data on the identity of the floppases that are 
involved in the outward movement of PS. The inward translocation of 
aminophospholipids is due to the activity of the third family of enzymes, 
aminophospholipid translocases (APLTs). The proteins in this family selectively 
translocate, in an ATP-dependent manner, PS and PE from the outer to the inner leaflet of 
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the plasma membrane. Inactivation of these proteins during apoptosis could lead to PS 
externalization. The exact protein or proteins responsible for the plasma membrane APLT 
activity has not yet been identified (Ravichandran 2007, Kerr 1972, Fadok 1999). 
 
1.3 Aminophospholipid Translocase activity and P-Type ATPases: 
           In 1984, the first evidence for the involvement of a membrane protein in the 
maintenance of phospholipid asymmetry was demonstrated by Seigneuret and Devaux 
(Seigneuret 1984). Their experiment showed the specific inward movement of spin-
labeled analogs of phosphatidylserine in human erythrocyte membranes. Other 
researchers replicated their results using fluorescent (Connor 1988) and radiolabeled  
(Tilley 1986) phosphatidylserine analogs (Bevers 1999). This membrane protein was 
shown to be specific for aminophospholipids; thus, it was referred to as 
‘aminophospholipid translocase’ (APLT). In 1986, Zachowski et al showed that PS and 
PE were specific substrates for this transporter (Zachowski 1986). The APLT or APLT 
activity is ATP-dependent, consuming one molecule of ATP for each molecule of 
phospholipid transported (Beleznay 1993). In a query to identify the protein responsible 
for the APLT activity, Auland et al. purified and reconstituted a 110-kDa, Mg2+-
dependent ATPase from human erythrocyte membranes. In 1996 Tang and coworkers 
(Tang 1996) cloned the cDNA of a Mg2+-ATPase II (presently named as Atp8a1) from 
bovine chromaffin granules, which was previously shown to require PS to be fully active 
(Moriyama 1988).  
           The ATPase activity of this Mg2+-ATPase II or Atp8a1 is vanadate and N-
ethylmaleimide (NEM) sensitive, just as the APLT activity was shown to be. It has been 
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purified from different sources, including chromaffin granules, clathrin-coated vesicles, 
and plasma membrane of erythrocytes (Ding 2000). Atp8a1 is a member of the fourth 
subfamily of P-type ATPases, which includes five yeast and fourteen human members. 
Atp8a1 is homologous to a TGN-resident protein in yeast encoded by the drs2 gene 
(Lenoir 2007) and to the C. elegans Tat-1protein (Zullig 2007, Darland-Ransom 2008b) . 
Although there are controversies with the Drs2p-mediated plasma membrane NBD-PS 
translocation activity, Atp81 and Drs2p were the first members of the type IV subfamily 
of P-type ATPases, also known as putative APLTs. 
           The expected structure of P-Type ATPases consists of ten transmembrane domains 
with the amino- and carboxy-termini extending toward the cytoplasm. The P-type 
ATPase-specific sequences and an ATP-binding site are located in the large intracellular 
loop. One of the P-type ATPase-specific sequences is known as the P-signature sequence, 
‘DKTGT[L,I,V,M][T,I,S]’. The aspartic acid residue in this sequence is essential for the 
phosphorylation/dephosphorylation reaction of the enzyme. Studies have shown that 
mutation of this residue impairs the ATPase activity of the enzyme without affecting 
substrate or ATP binding. In the mechanism by which P-type ATPases translocate their 
substrates across a membrane, at least four conformational changes occur to cause this 
translocation. Upon binding of a substrate (ion 1), a conformational change occurs 
causing phosphorylation of the enzyme by Mg2+-ATP at the aspartic acid residue. The 
phosphorylated enzyme increases its affinity for a second substrate (ion 2), while 
releasing the first ion on the other side of the membrane. The binding of the second 
substrate causes another conformational change triggering the hydrolysis of the aspartic 
acid-phosphate. A third conformational change occurs leading to the release of the 
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second substrate. The enzyme increases its affinity for the first ion starting the cycle 
again (Kuhlbrandt 2004)  (Figure 1).  
           In type-IV P-type ATPases, found only in eukaryotes, the metal interacting amino 
acids in transmembrane domains 4 and 6 of most cation-transporting P-type ATPases are 
replaced by hydrophobic amino acids (Kuhlbrandt 2004). The phylogenetic relationship 
between members of this subfamily is shown in Figure 2. The closest paralog of Atp8a1  
(U75321) is Atp8a2 (AF156550), which is also a putative flippase with 67% sequence 
identity with Atp8a1 (Figure 3).  
 
1.4 Atp8a1 
           Atp8a1 has been the candidate for the plasma membrane APLT for many years. 
Most of what is known about the APLT activity and Atp8a1 has been established in 
human erythrocytes, yeast and recently in C. elegans. No studies have been previously 
done in mouse neuronal cells or cancer cells.  mRNA expression of Atp8a1 is high in 
mouse brain, heart, and lung. In the mouse brain, Atp8a1 mRNA is highly expressed in 
the basal forebrain, amygdala and hippocampus (Halleck 1999).  
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OBJECTIVE OF THIS STUDY 
           Our goal was to understand the role of Atp8a1 as the plasma membrane 
aminophospholipid translocase (PM-APLT) of the neuroblastoma cell line N18 and of 
proliferating neuroblasts of the hippocampus. 
           In this project, we provide evidence showing that Atp8a1 is the PL-APLT of the 
neuroblastoma cell line N18. This is demonstrated through kinetic analysis of plasma 
membrane APLT activity after overexpression of Atp8a1 or suppression of its activity by 
using phosphorylation-site mutants.  Furthermore, the effect of the absence of Atp8a1 on 
PS exposure in proliferating brain cells is tested in an Atp8a1 (-/-) mouse line. 
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Figure 1: P-type ATPases ion-translocation cycle. The process starts in the E1 state 
with the binding of ion 1 (X+) to its high-affinity site in the membrane (M) domain from 
the cytoplasm, and the binding of Mg2+-ATP to the nucleotide-binding pocket (N). The 
protein then moves into the E1-P conformation in which the Mg2+-ATP is brought close 
to the phosphorylation domain (P, green). This results in phosphorylation of the Asp 
residue in the P-type signature domain. The protein enters E2-P conformation in which 
the TGE-containing face of the actuator domain (A, orange) is oriented toward the 
phosphorylation site where it binds to the Mg2+-ADP product leading to expulsion of the 
ADP molecule produced in the reaction and also ejection of the X+ ion into the 
extracellular fluid. The E2 state is set by the influx of ion 2 (Y+) triggering hydrolysis and 
releasing the phosphate and Mg2+ ions. The A domain reorients and the molecule returns 
back to the E1 state (Kühlbrandt 2004).  
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Figure 2: Phylogenetic analysis of the human and yeast Saccharomyces cerevisiae (in bold) type 4 ATPases (Paulusma 2005) 
  12 
Figure 3: Amino acid sequence alignment between Atp8a1 (accession number 
NM_009727) and Atp8a2 (accession number AF156550) shows a 67% sequence 
identity between the two type-IV P-type ATPases. The alignment between the two 
amino acid sequences was done using blast (http://blast.ncbi.nlm.nih.gov/Blast).
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Atp8a1 and Atp8a2 amino acid sequence comparison 
 
 
Atp8a1  24   VSEKTSLADQEEV--RTIFINQPQLTKFCNNHVSTAKYNVITFLPRFLYSQFRRAANSFFLFIALLQQIP  91 
             +S  TS+ DQ E   R I++NQ  L KFC+N +STAKY+V+TFLPRFLY Q RRAAN+FFLFIALLQQIP 
Atp8a2  1    MSRATSVGDQLEAPARIIYLNQSHLNKFCDNRISTAKYSVLTFLPRFLYEQIRRAANAFFLFIALLQQIP  70 
 
 
Atp8a1  92   PDVSPTGRYTTLVPLLFILAVAAIKEIIEDIKRHKADNAVNKKQTQVLRNGAWEIVHWEKVNVGDIVIIKG 161 
             PDVSPTGRYTTLVPL+ IL +A IKEIIED KRHKADNAVNKK+T VLRNG W  + W++V VGDIV + 
Atp8a2  71   PDVSPTGRYTTLVPLVIILTIAGIKEIIEDFKRHKADNAVNKKKTIVLRNGMWHTIMWKEVAVGDIVKVLN 140 
 
 
Atp8a1  162  KEYIPADTVLLSSSEPQAMCYIETSNLDGETNLKIRQGLPATSDIKDIDSLMRISGRIECESPNRHLYDF  231 
              +Y+PAD VL SSSEPQ MCY+ET+NLDGETNLKIRQGL  T+D++  D LM++SGRIECE PNRHLYDF  
Atp8a2  141  GQYLPADMVLFSSSEPQGMCYVETANLDGETNLKIRQGLSHTTDMQTRDVLMKLSGRIECEGPNRHLYDF  210 
 
 
Atp8a1  232  VGNIRLDGHGTVPLGADQILLRGAQLRNTQWVHGIVVYTGHDTKLMQNSTSPPLKLSNVERITNVQILIL  301 
              GN+ LDG  +V LG DQILLRG QLRNTQWV G+VVYTGHD+KLMQNST  PLK SNVE++TNVQIL+L 
Atp8a2  211  TGNLHLDGKSSVALGPDQILLRGTQLRNTQWVFGVVVYTGHDSKLMQNSTKAPLKRSNVEKVTNVQILVL  280 
 
 
Atp8a1  302  FCILIAMSLVCSVGSAIWNRRHSGKDWYLHLHYGGASNFGLNFLTFIILFNNLIPISLLVTLEVVKFTQA  371 
             F IL+ M+LV SVG+  WN  H GK WY+      + NFG N LTFIIL+NNLIPISLLVTLEVVK+TQA  
Atp8a2 281   FGILLVMALVSSVGALFWNGSHGGKSWYIKKMDTNSDNFGYNLLTFIILYNNLIPISLLVTLEVVKYTQA  350 
 
 
Atp8a1  372  YFINWDLDMHYEPTDTAAMARTSNLNEELGQVKYIFSDKTGTLTCNVMQFKKCTIAGVAYGQSSQFGDEK  441 
              FINWD+DM+ Y  DT AMARTSNLNEELGQVKY+FSDKTGTLTCN+M FKKC+IAGV YG   +   E+ 
Atp8a2  351  LFINWDMDMY YIENDTPAMARTSNLNEELGQVKYLFSDKTGTLTCNIMNFKKCSIAGVTYGHFPELAREQ 420 
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Figure 3 (continued) 
 
Atp8a1  442  T----------------FNDPSLLDNLQNNHPTAPIICEFLTMMAVCHTAVPEREGDKIIYQAASPDEGA  495 
             +                FNDP LL N+++ HPTAP I EFLT++AVCHT VPE++GD+IIYQA+SPDE A 
Atp8a2  421  SSDDFCRMTSCTNDSCDFNDPRLLKNIEDQHPTAPCIQEFLTLLAVCHTVVPEKDGDEIIYQASSPDEAA  490 
 
 
Atp8a1  496  LVRAAKQLNFVFTGRTPDSVIIDSLGQEERYELLNVLEFTSARKRMSVVVRTPSGKLRLYCKGADTVIYE  565 
             LV+ AK+L FVFTGRTP SVII+++GQE+ + +LNVLEF+S RKRMSV+VR PSG+LRLYCKGAD VI+E 
Atp8a2  491  LVKGAKKLGFVFTGRTPYSVIIEAMGQEQTFGILNVLEFSSDRKRMSVIVRLPSGQLRLYCKGADNVIFE  560 
 
 
Atp8a1  566  RLAETSKYKEITLKHLEQFATEGLRTLCFAVAEISESDFEEWRAVYHRASTSVQNRLLKLEESYELIEKN  635 
             RL++ SKY E TL HLE FATEGLRTLC A A++SE+++EEW  VY  AS  +++R  +LEE YE+IEKN 
Atp8a2  561  RLSKDSKYMEETLCHLEYFATEGLRTLCVAYADLSENEYEEWLKVYQEASIILKDRAQRLEECYEIIEKN  630 
 
 
Atp8a1  636  LQLLGATAIEDKLQDQVPETIETLMKADIKIWILTGDKQETAINIGHSCRLLKRNMGMIVINEGSLDGTR  705 
             L LLGATAIED+LQ  VPETI TL+KA+IKIW+LTGDKQETAINIG+SCRL+ +NM +I++ E SLD TR 
Atp8a2  631  LLLLGATAIEDRLQAGVPETIATLLKAEIKIWVLTGDKQETAINIGYSCRLVSQNMALILLKEDSLDATR  700 
 
 
Atp8a1  706  ETLSRHCTTLGDALRKENDFALIIDGKTLKYALTFGVRQYFLDLALSCKAVICCRVSPLQKSEVVEMVKK  775 
               +++HCT LG+ L KEND ALIIDG TLKYAL+F VR+ FLDLALSCKAVICCRVSPLQKSE+V++VKK  
Atp8a2  701  AAITQHCTDLGNLLGKENDVALIIDGHTLKYALSFEVRRSFLDLALSCKAVICCRVSPLQKSEIVDVVKK  770 
 
 
Atp8a1  776  QVKVITLAIGDGANDVSMIQTAHVGVGISGNEGLQAANSSDYSIAQFKYLKNLLMVHGAWNYNRVSKCIL  845 
             +VK ITLAIGDGANDV MIQTAHVGVGISGNEG+QA N+SDY+IAQF YL+ LL+VHGAW+YNRV+KCIL 
Atp8a2  771  RVKAITLAIGDGANDVGMIQTAHVGVGISGNEGMQATNNSDYAIAQFSYLEKLLLVHGAWSYNRVTKCIL  840 
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Figure 3 (continued) 
 
 
Atp8a1  846  YCFYKNIVLYIIEIWFAFVNGFSGQILFERWCIGLYNVMFTAMPPLTLGIFERSCRKENMLKYPELYKTS  915 
             YCFYKN+VLYIIE+WFAFVNGFSGQILFERWCIGLYNV+FTA+PP TLGIFERSC +E+ML++P+LY+ + 
Atp8a2  841  YCFYKNVVLYIIELWFAFVNGFSGQILFERWCIGLYNVIFTALPPFTLGIFERSCTQESMLRFPQLYRIT  910 
 
 
Atp8a1  916  QNALDFNTKVFWVHCLNGLFHSVILFWFPLKALQYGTVFGNGKTSDYLLLGNFVYTFVVITVCLKAGLET  985 
             QNA  FNTKVFW HC+N L HS+ILFW P+KAL++ T   +G  +DYL +GN VYT+VV+TVCLKAGLET 
Atp8a2  911  QNAEGFNTKVFWGHCINALVHSLILFWVPMKALEHDTPVTSGHATDYLFVGNIVYTYVVVTVCLKAGLET  980 
 
 
Atp8a1  986  SYWTWFSHIAIWGSIALWVVFFGIYSSLWPAVPMAPDMSGEAAMLFSSGVFWVGLLSIPVASLLLDVLYK  1055 
             + WT FSH+A+WGS+ +W+VFFG+YS++WP +P+APDM+A   M+ SS  FW+GL  +P A L+ DV ++ 
Atp8a2  981  TAWTKFSHLAVWGSMLIWLVFFGVYSTIWPTIPIAPDMKGQATMVLSSAYFWLGLFLVPTACLIEDVAWR  1050 
 
 
Atp8a1 1056  VIKRTAFKTLVDEVQELEAKSQDPGAVVL----GKSLTERAQLLKNVFKKNHVNLYRSESLQQNLLHGYA 1121 
               K T  KTL++EVQELE KS+  G  +L    GK + ER +L+K + +K    L+R+ S+QQ + HGYA  
Atp8a2 1051  AAKHTCKKTLLEEVQELETKSRVMGKAMLRDSNGKRMNERDRLIKRLSRKTPPTLFRTGSIQQCVSHGYA  1120 
 
 
Atp8a1 1122  FSQDENGIVSQSEVIRAYDTTKQ 1144 
             FSQ+E+G V+Q E++RAYDTTK+ 
Atp8a2 1121  FSQEEHGAVTQEEIVRAYDTTKE 1143 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Reagents:  
           For immunoblotting or immunohistochemistry analysis, the following antibodies 
were used: Monoclonal Anti-β-Actin antibody (Sigma, MO, USA), Ab-B (Ding 2000), 
custom made Atp8a2 antibody (Aves Labs Inc, OR, USA), goat anti-mouse IgG-HRP 
and anti-rabbit IgG-HRP antibodies (Santa Cruz Biotechnology Inc, CA, USA), Alexa 
Fluor 488 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-mouse IgG (Invitrogen 
Corporation, CA, USA). For PCR and cloning, the following reagents were used: the 
TOPO-TA™ Cloning Kit, the THERMOSCRIPT™ RT-System, the Platinum® Taq 
High Fidelity thermostable DNA polymerase, agarose and dNTPs mixture (Invitrogen 
Corporation, CA, USA). The QIAprep Miniprep plasmid DNA isolation kit, QIAquick 
PCR purification kit, QIAquick gel extraction kit, RNeasy Mini kit including 
QIAShredder™ columns and on-column DNase digestion kit were purchased from 
(QIAGEN, CA, USA). For genotyping, Proteinase K (Invitrogen Corporation, CA, USA) 
was used. For promoter analysis, the pGL3-Basic (no promoter) and pGL3-Promoter 
(SV40 promoter) firefly luciferase reporter plasmids, pRL-TK vector and the Dual 
Luciferase Reporter (DLR) assay kit (Promega, WI, USA). 
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2.2 Animals: 
           C57 mouse was used for gDNA and RNA isolation. Mice were obtained from 
Taconic and kept in the CSI Animal Facility.  Atp8a1 (+/-) mice were purchased from 
Jackson Laboratories and then bred and genotyped to obtain Atp8a1 (-/-) mice. 
 
2.3. Cell lines 
           For our experiments, the following cell lines were used: mouse neuroblastoma cell 
line N18 (generously provided by Dr. Efrain Azmitia, New York University, NY), mouse 
hippocampal neuron-derived hybrid neuroblastoma cell line HN2 (obtained from the CSI 
cell depository), mouse melanoma cell line B16F10 (generously provided by Dr. Susan 
Rotenberg, Queens College, NY). All cells were cultured in DMEM (Dulbecco's 
Modified Eagles Medium) containing 10% FBS (Fetal Bovine Serum) and 1% PS 
(Penicillin–Streptomycin). NIH3T3 cell line (generous gift from Dr. Yu-Wen Hwang's 
lab at the NY State Institute For Basic Research, Staten Island, NY) were cultured with 
DMEM media containing 10% Calf Serum and 1% PS.  
 
2.4 Atp8a1 and Atp8a2 expression vectors:  
           Mouse brain RNA was isolated using the RNeasy Mini Kit (QIAGEN, CA, USA) 
and the cDNA was obtained by using ThermoScript™ RT-PCR System plus Platinum® 
Taq DNA Polymerase (Invitrogen Corporation, CA, USA).  For amplification of Atp8a1 
or Atp8a2, primers were designed with the addition of restriction sites for directional 
cloning (Table 1). The downstream primer (the antisense primer) included the coding 
sequence but not the stop codon, to allow insertion into pCDNA6.1/ myc-HisA (for 
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Atp8a1) and/or pcDNA6.1/ myc-His C (for Atp8a2) in-frame with the myc-His sequences 
to eventually achieve expression of epitope-tagged Atp8a1 and Atp8a2.  
 
2.5 Phosphorylation-site mutant construct of Atp8a1:  
           The aspartate residue in the P-type signature sequence ‘DKTGTL’ was mutated to 
either lysine (D409K) or glutamate (D409E) using the GeneTailor™ Mutagenesis 
System (Invitrogen, CA, USA) as previously described in Levano et al. (Levano et al. 
2009). Briefly, Atp8a1-pcDNA6/myc-His A construct was first methylated and PCR 
amplified using two overlapping primers (Table 1). As shown in Figure 4, one of the two 
primers contained the required mutation (D409K) or (D409E) in order to produce the 
desired mutation within the ‘DKTGTL’ motif. The PCR product was transformed into 
mcrBC+ E.coli. Unmutated, methylated parent plasmid was digested in the mcrBC+ E.coli 
and only the mutated plasmid was obtained after lysis and DNA isolation. 
 
                                                                397                         409                      
amino acid:     L     G     Q      V     K      Y      I      F     S      D      K      T      G     T     L   
cDNA:          CTTGGCCAGGTTAAATACATATTTTCTGACAAAACTGGGACCCTG 
 
Figure 4: Fragment of the amino acid and cDNA sequences of the Mus musculus 
Atp8a1. Underlined is the DKTGTLT sequence motif. 
 
 
 
  19 
2.6 Transfection of cells with plasmid DNA:   
           Tumor cells, plated in poly-L-lysine-coated six-well plates, were allowed to grow 
up to 60% confluency.  For the non-tumor cells, which were differentiated after 
transfection, were allowed to grow up to 70-80% confluency.  At this point, the cells 
were transfected as described here.  The plasmid DNA (3 µg) was diluted in 200 µl 150 
mM NaCl (for all the tumor cells) and the mixture was gently vortexed and spun briefly.  
Next, ExGen transfection reagent (Fermentas, Inc., MD), at 7:1 molar equivalent ratio for 
amine in polyethyleneimine (in the reagent) vs DNA, was added to the DNA solution.  
This amounts to 11.52 µl of the reagent per sample per well. For HN2 cells, the DNA 
was dissolved 100 µl of 5% glucose and then the ExGen reagent, adjusted to 100 µl with 
5% glucose, was added to the DNA solution.  The mixture was vortexed for 10 s and then 
incubated for 10 min at room temperature.  The medium in each well of cells was 
replaced with 1.8 ml of serum-free DMEM and then the 200 µl of DNA-ExGen complex 
was added to it, followed by gentle rocking to achieve even distribution of the complex.  
For cotransfection of pEGFP or pAsRed2-N1, 2.4 µg of the experimental plasmid was 
mixed with 0.6 µg of pEGFP or pAsRed2-N1 in 200 µl of 5% NaCl or 5% glucose.  
Typically, the cells were allowed to incubate for three hours in a 37-°C CO2 incubator, 
following which fetal bovine serum (FBS) was added to each well to a final concentration 
of 10%, and then the cells were allowed to incubate overnight in the incubator.  The 
medium was then changed to DMEM containing 10% FBS and 1% Pen-Strep for tumor 
cells or the differentiation medium and the cells visualized using fluorescence 
microscopy for transfection.  Differentiation of the HN2 and SN48 cells was achieved in 
1% serum-containing DMEM containing 5 µM retinoic acid.  Control wells were 
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transfected with the same amount of empty vector, which, in this case, was pCDNA6.1. 
 
2.7 Aminophospholipid translocase assay:  
           The APLT activity of the plasma membrane was measured in cells using NBD-PS 
(1-Oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-Glycero-3-
Phospho-L-Serine) (Avanti Polar Lipids, Inc.) by modifying reported procedures 
(Tyurina 2007, McIntyre 1991, Connor 1992). All assays were completed using triplicate 
samples.  
           For the time-course APLT assays, briefly, cells (~106) were washed and 
resuspended in 1 ml ice-cold incubation buffer (136 mM NaCl, 2.7 mM KCl, 2 mM 
MgCl2, 5 mM glucose, 10 mM HEPES, 500 µM PMSF, pH 7.5). Cells were then 
incubated with NBD-PS (10µM; dissolved in 12 µl of ethanol) on ice for 10 min allowing 
incorporation of NBD-PS to the outer leaflet of the plasma membrane, while preventing 
translocation and endocytosis. Unbound NBD-PS was then removed by washing the cells 
with ice-cold incubation buffer. Cells were resuspended in 1 ml ice-cold incubation 
buffer and incubated at 28 °C for 0, 5, 10 and 15 min, allowing translocation of PS 
(NBD-PS). Untranslocated NBD-PS fluorescence remaining in the outer leaflet of the 
plasma membrane was removed by modifying NBD (7-nitro-2,1,3-benzoxadiazol-4-yl) to 
the non-fluorescent fluorophore ABD (7-amino-2,1,3-benzoxadiazol-4-yl) (McIntyre 
1991) by incubating the cell suspension  with sodium dithionite (S2O4-2; 10mM) for 30 s 
on ice. Cells were then washed and resuspended in 220 µl of 1X PBS. For fluorescence 
analysis using a fluorescence plate reader (FLX800) set at excitation and emission 
wavelengths of 485 nm and 530 nm, the cell suspension (200 µl sample) was placed in a 
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well of a 96 well-plate. For microscopy, cells were resuspended in mounting medium and 
placed on a slide (Figure 5).  
           For the substrate concentration-dependant APLT assays, cells (~106) were 
washed and resuspended in 1 ml ice-cold incubation buffer. Increasing concentrations of 
NBD-PS in 12 µl ethanol (ice-cold) were then added to the 1 ml cell suspension to obtain 
the following concentrations: (in µM) 0.35, 0.5, 0.75, 1, 2, 4. The cell suspension was 
incubated for 10 min on ice. Cells were then washed, resuspended in 1 ml ice-cold 
incubation buffer, and incubated at 28 °C for 10 min (time at which translocation is in the 
linear range). After the 10 min incubation, the cell suspension was placed back on ice. 
NBD-PS fluorescence remaining in the outer leaflet of the plasma membrane was 
removed by incubating the cell suspension on ice with sodium dithionite (10 mM) for 30 
s. Cells were then washed and resuspended in 220 µl of 1X PBS. 200 µl of each cell 
suspension was placed in a well of a 96-well plate for fluorescence analysis using a 
fluorescence plate reader as stated before.  
           For all APLT assays, to record the background fluorescence, ~106 cells per sample 
were incubated with 12 µl of ethanol without NBD-PS and then at 28 °C for 10 min, 
followed by the same treatment as performed for the NBD-PS containing samples. To 
account for the loss of cells during the entire assay, 20 µl of each cell suspension was 
used to count cells (using a hemocytometer). All fluorescence values were normalized to 
105 cells. The average of the normalized background fluorescence was subtracted from 
each normalized fluorescence value obtained from the NBD-PS-treated samples. For the 
time-course APLT assays, we plotted as fluorescence units/105 cells versus time (min). 
For the concentration-dependant APLT assays, the fluorescence values were converted to 
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micromole of NBD-PS by comparing with a standard curve constructed using 
fluorescence readings from NBD-PS/PC vesicles containing increasing concentrations of 
NBD-PS (in µM, 0.1, 0.5, 1, 2.5, and 5). The micromole values were then converted into 
NBD-PS molecules translocated by using the Avogadro number.  Lineweaver-Burk plots 
were constructed by using V0 in molecules/105 cells/min and [S] as concentrations of 
NBD-PS in µM. 
           Determination of the actual NBD-PS concentration in the outer leaflet of the 
plasma membrane :  A fourth sample was run in parallel to the substrate concentration-
dependant APLT assay to account for the true NBD-PS concentration in the outer leaflet 
of the plasma membrane. Briefly, cells were washed, resuspended, and incubated with 
NBD-PS (0.35, 0.5, 0.75, 1, 2, 4 µM) as stated previously for 10 min on ice. Then, cells 
were washed and resuspended in 220 µl of 1X PBS. Each cell suspension (200 µl) was 
placed in one well of a 96 well plate and all the samples were analyzed using a 
fluorescence plate reader. The fluorescence values were converted to µmoles of NBD-PS 
by comparing with a standard curve constructed as stated previously. After finding the 
thickness of the plasma membrane (~6 nm) (Kuchel 1988) and the diameter of a cell in 
suspension (~14 µmeters) (Arms 1995) (Fig. 6), we calculated the volume of the outer 
leaflet of the plasma membrane (1.85 µm3). Then, we divided the NBD-PS µM 
concentrations by the volume of the outer leaflet of the plasma membrane calculated 
(Figure 6).  
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2.8 Membrane isolation using the Mem-PER kit:  
           About 5 x 105 cells in microcentrifuge tubes were pelleted down, washed once 
with PBS and then supplemented with 150 µl of Reagent A (lysis buffer) from the Mem-
Per kit (Pierce).  The mixture was incubated at room temperature for 10 min and then 450 
µl of Reagent B/C was added to the mixture, followed by incubation for 30 min on ice.  
The mixture was then centrifuged at 10,000-x g for 3 min.  The supernatant, containing 
solubilized proteins, was separated and then incubated at 37 °C for 10 min to separate 
phases.  Following this, the mixture was centrifuged at 10, 000 x g for 2 min.  The top 
layer, containing the hydrophilic proteins, and the bottom layer, containing the 
hydrophobic membrane proteins, were separated.  The fractions separated were assayed 
for protein and then aliquots containing equal mass of protein were resolved using SDS-
PAGE and Western blotting as discussed in the following section. 
 
2.9 SDS-PAGE and Immunoblotting analysis:  
           To determine the expression levels of Atp8a1, tissue and cell lysates prepared in 
RIPA buffer (PBS containing 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 0.5 mM 
Na3VO4, protease inhibitor cocktail, PMSF) or in a buffer from the Mem-PER kit were 
used. Aliquots containing 50-100 µg protein were mixed with SDS-PAGE treatment 
buffer and boiled for 5 min. Proteins were resolved on a 7-16% gradient SDS-PAGE gel 
and then transferred to nitrocellulose membrane. For Atp8a1 analysis, blots were blocked 
overnight with 5% nonfat dry milk in 0.1% Tween-TBS and subsequently incubated 
overnight with Atp8a1 antibody (antibody B) (1:10,000 dilution). Following three washes 
with 0.1% Tween-TBS, blots were incubated for 1 h with horseradish peroxidase-labeled 
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goat-anti-rabbit IgG (1:20,000). Protein bands were detected using Super signal West 
Pico kit (Pierce). For normalization, blots were stripped using a stripping buffer (0.25M 
glycine, pH 2.0) for 1hr at room temperature, re-blocked and probed with monoclonal β-
Actin antibody (Sigma) in a 1:10,000 dilution with overnight incubation. After 
subsequent washes, blots were incubated with horseradish peroxidase-labeled goat-anti-
mouse IgG (1:50,000).  
 
2.10 Annexin V staining:  
           Annexin V labeling of surface PS was monitored using the Vybrant® Apoptosis 
Assay Kit #2 – Alexa Fluor® 488 annexin V/propidium iodide (Invitrogen, CA, USA) 
according to the manufacturer’s instructions. Briefly, cells were resuspended in 500 µl of 
1X annexin-binding buffer (for slice cultures 100 µl of 1X annexin-binding buffer was 
used). Alexa Fluor® 488 annexin V (5µl), 100 µg/ml propidium iodide (PI) solution (1 
µl) and Hoechst 33348 (1µM) were added to 100 µl of the cell suspension (or slice 
culture), followed by incubation at room temperature for 20 min. Cells (or slice cultures) 
were then washed with 1X annexin-binding buffer and mounted on slides with ProLong® 
Gold antifade reagent (Invitrogen, CA, USA) for visualization and photography using a 
fluorescence microscopy. 
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2.11 Genotyping to identify Atp8a1 (-/-) pups: 
           For mouse-tail genomic DNA extraction, a modified protocol from Molecular 
cloning Sambrook Russell was used. Briefly, mouse tails (about 4-mm long) were 
collected and lysed in SNET lysis buffer containing 20 mM Tris-Cl (pH 8), 5 mM EDTA 
(pH 8), 400 mM NaCl, 1% (w/v) SDS and 400 µg/ml of Proteinase K (stock 20 mg/ml). 
After overnight incubation at 55 °C with vigorous shaking, the tail DNA solution was 
incubated with phenol:chloroform:isoamyl (25:24:1) alcohol solution at room 
temperature for 30 min with shaking. The aqueous phase was separated and incubated 
with equal volume of isopropanol to precipitate the genomic DNA. DNA pellets were 
resuspended in 1 mM Tris HCl/ 0.1 mM EDTA. The primer sequences and strategy were 
obtained from the JAX labs. Three primers were used to differentiate between the Atp8a1 
knockout product (437-bp) from the wild type Atp8a1 product (253-bp) gene (IMR6315: 
GCT GTC AAT GAT GCG CTT CCT CCT C, IMR6314: GGG CCA GCT CAT TCC 
TCC CAC TCA T, IMR6313: TGT TCA CAG ATC AAA AGA CCC TAT C). PCR 
analysis was performed in a 50 µl reaction volume containing 500 ng of extracted 
genomic DNA, 0.2 mM dNTP mix, 2 mM MgSO4, 0.2 µM primers, and 2.0 units of 
Platinum® Taq DNA Polymerase High Fidelity (Invitrogen, CA, USA). PCR conditions 
were 95°C for 30 s followed by 35 cycles of denaturation at 94 °C for 30 s, annealing at 
55 °C for 30 s, and extension at 68 °C for 1 min. PCR products were analyzed by 1% 
agarose gel electrophoresis with ethidium bromide staining in comparison to a 1-kb 
ladder (Invitrogen, CA, USA). 
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2.12 Dissociation of DG cells:  
           Dentate Gyrus (DG) cells were obtained from ATP8a1 KO and wild type 
C57BL/J6 mice. Briefly, mice were anesthetized with ketamine (100 mg/Kg) and 
decapitated. Under sterile conditions, the hippocampus was isolated. Transverse slices 
(600-µm thick) were prepared using a tissue chopper (Stoelting, IL, USA). The DG was 
removed from the hippocampus using the Harris Uni-Core, Hole 1.5-mm chopper (Ted 
Pella, Inc., CA, USA). DG slices were incubated in trypsin-EDTA (2.5 g/L) for 5 min at 
37 °C. The tissue was further dissociated by gentle triturating with a pipette. Dissociated 
cells were centrifuged, washed once with 1X PBS, and then immediately processed for 
annexin V staining.  
 
2.13 Organotypic culture of hippocampal slices:  
           This protocol has been modified from Mehta et al 2007 (Mehta 2007). Briefly, as 
stated above, the hippocampus was isolated under sterile conditions and placed in 
modified Gey's balanced salt solution (mGBSS) (pre-chilled to 4°C) while bubbling a 
mixture of 95% O2 and 5% CO2.  Transverse slices (400-µm thick) were prepared using a 
tissue chopper (Stoelting, IL, USA). Slices were placed on Millicell CM filters 
(Millipore, MA, USA) in a six-well dish with 1 mL of medium. The slices were kept on 
high potassium culture medium (25% horse serum, 50% basal essential media-Eagles, 
25% Earle's balanced salt solution (EBSS), 25 mmol/L Na-HEPES, 1 mmol/L glutamine, 
28 mmol/L glucose, pH 7.2) for the first 2 days. After incubation at 32°C in a 5% CO2 
atmosphere, the culture medium was changed to physiological potassium slice culture 
medium (20% dialyzed fetal bovine serum, 5% basal essential media-Eagles, and EBSS 
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modified to adjust the potassium concentration to 2.66 mmol/L). After 20% dialyzed 
serum treatment for 2 days, slices were used for annexin V staining.  
 
2.14 Evaluation of hippocampal function of the Atp8a1 (-/-) mice:  
           Briefly, to test the hippocampus dependent visual discrimination learning, the 
Water T-Maze was used. Briefly, the T-maze was constructed from a plastic reservoir 
containing a start arm (30 cm long and 15 cm wide). The exit of the start arm was located 
at the center of a perpendicular corridor (80 cm long and 15 cm wide) giving a left and a 
right arm (each of 32.5 cm long).  The start arm and the perpendicular corridor were 
filled with water  (made opaque with white Crayola non-toxic white powder paint) that 
was 23º C. The depth of the water was 15 cm.  
           Every mouse underwent training on the first day, where they were allowed to run 
through 10 trails.  During each trial, each mouse was placed in the start arm of the T-
Maze, which was filled with water. They were supposed to reach the horizontal arms 
where in one of the arms, at the far end, was placed a submerged platform, which acted as 
a reward and reinforcement for them to escape the water. There were 2 spatial cues, one 
in each arm and the triangle spatial cue was always supposed to be in the arm that had the 
submerged platform. During each trial, the platform, along with the cue, was randomly 
switched between the two horizontal arms.  After the first training day, they underwent 8 
trials everyday because it was realized from the experience on the training day that last 2 
trials in a total of 10 were really exhausting for the mice. The maximum testing period 
was pre-decided to be 12 consecutive days. A mouse that was able to complete eight out 
of ten trials per day without error for four consecutive days was considered to have 
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learned the task. The errors charged were: (1) if the mouse entered the arm of the T-maze 
where the platform was not located with all four paws; (2) if the animal turned back 
around and re-entered the start arm.  At the end, the number of days needed for each 
mouse to reach learning criteria was recorded and compared to assess visual 
discriminatory learning ability (Teather 2002, Denayer 2008). 
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Table 1: Primers used for site-directed mutagenesis 
 
 
 
 
Vector Constructs Name Sequence (5’-3’) Source 
Atp8a1-pcDNA6.1/myc-His A Fwd-mATPase-HindIII CCC AAG CTT CGA GAC CCA CCT GCA GGG 
GCT 
 
NM_009727 
Atp8a1-pcDNA6.1/myc-His A Rvs-mATPase-SalI TTG AC GTC GAC CCA CTC ATC GGG CCT 
CTG TTT G 
NM_009727 
Atp8a2-pcdDNA6.1/myc-His C mATPaseIb-S-F-KpnI CGG GGT ACC TCG ATT CTG CAG GAC CCG 
TTC G  
AF156550 
Atp8a2-pcdDNA6.1/myc-His C mATPaseIb-S-r-Not I ATA GTT TA GCG GCC GCT TTT CTT CCT TGA 
ATT CTC TTT GGT GGT ATC ATA AGC GCG 
AF156550 
Atp8a1-D409K/E ATPASEII-D409K/E-R1 CTTGAACCGGTCCAATTTATGTATAAAAGA NM_009727 
Atp8a1-D409K ATPASEII-D409K-F1 AAATACATATTTTCTAAGAAAACTGGGACC NM_009727 
Atp8a1-D409E ATPASEII-D409E-F2 AAATACATATTTTCTGAGAAAACTGGGACC NM_009727 
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            Figure 5: Our modified aminophospholipid translocase (APLT) assay.
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Figure 6: Calculating NBD-PS concentration incorporated into the outer leaflet of the plasma membrane. (1) Measuring true 
NBD-PS concentration. & (2) Conversion of the fluorescence values to µM/volume of outer leaflet of plasma membrane.  
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CHAPTER 3 
RESULTS 
3.1 NBD-phosphatidylserine translocation from the outer to inner leaflet of the 
plasma membrane of neuroblastoma cell line N18: 
We began our study in determining the role of Atp8a1 in the plasma membrane APLT 
activity of neuronal cells by testing our modified APLT assay in a time-course assay 
performed on untransfected neuroblastoma cells (N18). In Figure 7, a time-dependent 
APLT assay is shown, in which by fluorescence microscopy, NBD-PS internalization is 
observed as incubation at 28 °C is continued (temperature at which NBD-PS 
translocation initiates) in the mouse neuroblastoma cell line N18. As described in 
materials and methods, in the APLT assay used in our studies, NBD-PS is allowed to 
incorporate into the outer leaflet of the plasma membrane at 4 °C for 10 min. 
Spontaneous incorporation of NBD-PS into suspended cells at 4 °C has been previously 
shown by Connor and Schroit (Connor 1989). At this temperature, aminophospholipid 
translocation or endocytosis, does not occur (Suzuki 1997). In order to measure only 
fluorescence representing NBD-PS translocated to the inner leaflet of the plasma 
membrane, NBD-PS fluorescence remaining in the outer leaflet (untranslocated NBD-PS) 
needs to be removed. In 1991, McIntyre et al developed a method for chemically 
modifying NBD to a nonfluorescent fluorophore (ABD) in both artificial and biological 
membrane using dithionite treatment. Figure 8 shows the reaction mechanism for the 
reduction of NBD-PS by dithionite. In their studies, McIntyre et al showed that sodium 
dithionite reacts only with the NBD-PS present in the outer leaflet of the plasma 
membrane (McIntyre 1991). Thus, in our modified APLT assay, after incubation at 28 
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°C, NBD-PS fluorescence remaining in the outer leaflet of the plasma membrane was 
removed by treating the cells with sodium dithionite. The final fluorescence observed 
corresponds to NBD-PS translocated by the APLT enzyme to the inner layer of the 
plasma membrane. An increase or decrease in fluorescence in the dithionite-treated cells 
corresponds to an increase or decrease in the plasma membrane APLT activity, 
respectively. 
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                            NBD-PS                        Sodium Dithionite                                                                                ABD-PS 
R Group = phosphatidylserine (1,2-dioleoyl-sn-glycero-3-phospho-L-serine) 
 
Figure 7: Reduction of NBD-PS (1-Oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-Glycero-3-Phospho-L-
Serine) to ABD-PS 1-Oleoyl-2-[6-[(7-amino-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-Glycero-3-Phospho-L-Serine by 
sodium dithionite (McIntyre 1991).  
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Figure 8: Time-dependent translocation of NBD-PS from outer to inner leaflet of the 
plasma membrane of N18 cells.  The N18 cells were first labeled with NBD-PS on ice 
for 10 min (see methods), washed free of NBD-PS, and then resuspended in an ice-cold 
incubation buffer, followed by incubation at 28 °C for increasing periods of time. After 
incubation, the cell suspension was placed back on ice. In a parallel set of samples the 
NBD-PS fluorescence from the outer leaflet of the membrane was removed by incubation 
on ice in 10 mM sodium dithionite for 30 s. The cells were then washed and resuspended 
in mounting fluid for fluorescence microscopy. 
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Kinetics of NBD-PS internalization: 
 
 ___________No Dithionite____________  ____________Dithionite______________ 
 
        
0 min---------------------------------------------  ----------------------------------------------------- 
       
2 min---------------------------------------------  ----------------------------------------------------- 
       
5 min---------------------------------------------  ----------------------------------------------------- 
       
7 min---------------------------------------------  ----------------------------------------------------- 
       
10 min--------------------------------------------  ---------------------------------------------------- 
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3.2 Overexpression of Atp8a1 causes an increase in the plasma membrane APLT 
activity of the neuroblastoma cell line N18, but not of differentiated HN2 cells:  
Having tested our modified APLT assay, and obtained reproducible results in 
measuring the plasma membrane APLT activity, we were then ready to determine 
changes in the plasma membrane APLT activity due to overexpression and/or 
suppression of Atp8a1. As stated in materials and methods, we measured fluorescence 
(corresponding to translocated NBD-PS) using a microplate reader, which allowed 
quantitative analysis of multiple samples.  
We began by overexpressing Atp8a1 in two cell lines: HN2 (hippocampal-derived 
cell-line) and N18. Trasient overexpression of Atp8a1 in both cell lines was confirmed by 
immunoblotting analysis using the Atp8a1 antibody kindly provided by Dr. Xie (Ab-B). 
Time-course APLT assays were used to measure the changes in APLT activity due to 
overexpression. The time-course was done as described in materials and methods, with 
incubation at 28° C up to 20 min. The data were expressed as increase in NBD-PS 
translocation (Atp8a1-empty vector) as percent empty vector transfeced cells.  
The results obtained showed that overexpression of Atp8a1 in N18 cells caused an 
increase in APLT activity (increase in NBD-PS fluorescence). However, when 
overexpressed in HN2 cells, Atp8a1 caused a decrease in APLT activity (Figure 9), 
possibly due to non-specific inhibition of the endogenous PM-APLT protein, which was 
therefore not Atp8a1.  
These results led us to hypothesize that Atp8a1 could be the plasma membrane 
APLT enzyme in N18 cells, but not in HN2. Although expression of Atp8a1 in HN2 cells 
was similar to that in N18 cells, Atp8a1 was not the main PM-APLT enzyme in these 
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cells. Thus the PM- APLT activity of Atp8a1 could be cell-type specific. A different 
homolog (e.g. Atp8a2, Atp8a1 closest homolog) could be functioning as the PM-APLT in 
the non-tumorigenic cell-line, HN2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  39 
 
Figure 9: Overexpression of Atp8a1 causes an increase in the plasma membrane 
APLT of N18 cells, but not of HN2. N18 and differentiated HN2 cells overexpressing 
Atp8a1 were harvested and subjected to time-course APLT assays as described in the 
materials and methods. (a) and (b) Overexpression of Atp8a1 in both N18 and HN2 cells 
was confirmed by immunoblotting using ab-B. (c) and (d) The time-course APLT assays 
show an increase in NBD-PS translocation in transfected N18 cells but not in transfected 
HN2.  
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3.3 Transient overexpression of Atp8a1 in N18 cells causes an increase in Vmax and 
no change in Km for the plasma membrane APLT:  
As stated above, overexpression of Atp8a1 in N18 cells causes an increase in 
NBD-PS translocation from the outer to the inner leaflet of the plasma membrane, an 
increase in the plasma membrane APLT activity. Thus, Atp8a1 could be the plasma 
membrane APLT in N18 cells. To further test this hypothesis, we approached this 
question through kinetic analysis, by measuring the Km and Vmax values using our 
modified APLT assay.   
Vmax and Km are the two parameters that define the kinetic behavior of an 
enzyme as a function of its substrate concentration. As stated in the Michaelis-Menten 
equation for a unimolecular reaction, a particular enzyme catalyzing the conversion of a 
specific substrate at a definite temperature and pH, displays one definite Km value. Thus, 
if a different enzyme molecule catalyzes the same reaction, its affinity for the substrate 
will be different, which will be reflected in a new Km value for this enzyme. Vmax is 
also a characteristic feature for the enzyme. If the Km value remains the same, then any 
change in Vmax value would reflect a change in the number of molecules of the enzyme. 
If Atp8a1 were indeed the plasma membrane APLT enzyme in N18 cells, then 
overexpression of this molecule would cause an increase in the Vmax value due to an 
increase in the number of APLT molecules catalyzing the translocation of NBD-PS. This 
was exactly what our results showed when Atp8a1 was transiently overexpressed in N18 
cells. 
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To determine changes in Km and Vmax values, substrate concentration-dependant 
PM-APLT assays were conducted. As described in materials and methods, different 
concentrations of NBD-PS were used (0, 0.035, 0.5, 0.75, 1, 2 µM).  The incubation time 
at 28 °C, which initiates translocation of NBD-PS, was maintained for 10 min (as shown 
in Figure 9, the APLT activity remains in the linear range up to 10 min). To correctly 
report the true Km values for the PM-APLT enzyme, the concentration of NBD-PS 
incorporated to the outer layer of the plasma membrane (before internalization) was 
determined. Briefly as described in materials and methods, parallel samples were used 
and cells were allowed to incorporate NBD-PS on ice for 10 min. After this, any unbound 
NBD-PS was removed and the fluorescence remaining was measured and converted to 
micromolar concentrations of NBD-PS by comparing with a standard curve constructed 
using fluorescence readings from NBD-PS/PC vesicles. Values were further converted to 
µmoles/min/cell and divided by the volume of the plasma membrane, which was 
calculated as shown in Figure 6.  In this experiment, overexpression of Atp8a1 in N18 
cells was confirmed by immunocytochemistry using a Myc-ab (as stated in Materials and 
Methods, cDNAs for Atp8a1 and Atp8a2 were cloned into the expression vector 
pcDNA6.1/myc-His in-framed with epitope tags) (Figure 10a). Substrate concentration-
dependant curves were obtained by plotting fluorescence units/105 cells (NBD-PS 
translocation from outer to inner leaflet) versus NBD-PS concentration (in µM) (Figure 
10 (b)). Km and Vmax values were calculated by graphing a Lineweaver-Burk plot 
(produced by plotting the inverse of substrate concentration against the inverse of the 
fluorescence units/105 cells). The Lineweaver-Burk plots for this experiment are shown 
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in Figure 10 (c) and (d). Table 2 summarizes results obtained from three separate 
substrate saturation APLT assays, each with triplicate samples. 
As expected, the results obtained show that overexpression of Atp8a1 in the N18 
cells causes no change in the Km value of the endogeneous PM-APLT that catalyzes the 
translocation of NBD-PS from the outer to the inner leaflet of the plasma membrane. 
There was a significantly 1.7-fold increase (paired t-test) in the Vmax value of this 
enzyme in the Atp8a1 overexpressing cells.  This strongly suggests that Atp8a1 is the 
plasma membrane APLT of the N18 cells (the same Km value) and that the process of 
transfection causes an overall increase in the number of APLT molecules in these cells 
(increase in Vmax value of APLT).  
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Figure 10: Transient overexpression of Atp8a1 in the mouse neuroblastoma cell line 
N18 causes an increase in Vmax without any change in Km. (a) The Atp8a1-
pcDNA6/myc-His transfected N18 cells showed immunostaining with a Myc Ab. (b) 
Substrate saturation curves show a Atp8a1-mediated increase in Vmax. (c) and (d) 
Lineweaver-Burk analysis reveals that overexpression of Atp8a1 in N18 cells elicits an 
increase in Vmax without affecting the Km value. 
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Table 2: Atp8a1 overexpression causes an increase in Vmax value of the APLT activity of the plasma membrane of N18 
cells. 
 
Exp. Empty Vector in N18 Atp8a1 in N18 
Fold Increase in Vmax in 
presence of Atp8a1 
 
Km 
(µM) 
Km(µM) Mean± 
Std.Dev. 
Vmax 
(molecules/ 
min/cell) Km (µM) 
Km(µM) Mean± 
Std.Dev. 
Vmax 
(molecules/ 
min/cell) 
Fold 
Increase Mean± Std.Dev 
1 0.033  0.76 x 104 0.029  1.1 x 104 1.45  
2 0.011 0.029±0.02 0.73 x 104 0.028 0.037±0.01 1.5 x 104 2.1 1.7±0.37 
3 0.043  2.6 x 104 0.053 P=0.3402 3.2 x 104 1.3 P=0.0449 
 
(Paired t-test was used for data analysis because, in each experiment, aliquots of the same batch of cells were transfected with 
the two vectors) 
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3.4 Transient expression of Atp8a1 phosphorylation-site mutants in N18 cells causes 
a decrease in the Vmax value without affecting the Km value for the plasma 
membrane APLT:    
To confirm our hypothesis that Atp8a1 is the plasma membrane APLT of N18 
cells, we examined the effect of suppressing At8a1 activity on the translocation of NBD-
PS in these cells.  
In order to suppress the activity of Atp8a1, we created phosphorylation site 
mutants. As stated previously, Atp8a1 is a P-type ATPase. All P-type ATPases are 
composed of four principal domains: the phosphorylation, the ATP-binding, the amino-
terminal and the membrane domain (lipid- binding site in Type IV P-type ATPase) 
(Kuhlbrandt 2004).  Thus, phosphorylation, ATP binding and phospholipid binding occur 
in separate domains. The ATPase activity of P-type ATPases depends on the 
phosphorylation of the aspartic residue at the beginning of the P-type signature domain: 
DKTGT[L,I,V,M][T,I,S], which is at position D409 in Atp8a1. To eliminate 
phosphorylation of this protein and, thereby, its ATPase activity, without affecting both 
ATP and PS binding (which occur in separate domains), we mutated the aspartic acid 
residue to a lysine residue. This non-conservative mutation allows binding of ATP and 
PS, but it prevents both hydrolysis of ATP and PS translocation. Thus, such mutants 
could function as a dominant negative versions of the target protein. Dominant negative 
mutation, first described by Herskowitz in 1987, is a tool used to study the function of 
specific genes. These mutants which compete with the wild-type enzyme for its substrate, 
can “efficiently inhibit any functional consequence of the wild-type enzymatic activity,” 
if the enzymatic reaction is limited by the substrate concentration (Sheppard 1994). Thus, 
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our Atp8a1 phosphorylation site mutants could be potential dominant negative mutants 
that could compete for PS binding.  Alternatively, in the presence of excess substrate, 
they could compete with the binding of Atp8a1 to a chaperone that assists the protein in 
being targeted to in the plasma membrane. Therefore, they could suppress Atp8a1 
activity in the cells. 
The site-directed mutagenesis was performed as described in Materials and 
Methods. Two Atp8a1 mutants were created: D409K and D409E. For the kinetic 
analysis, the Atp8a1-D409K mutant was used to suppress the activity of Atp8a1. 
Supporting our hypothesis, the results (Figure 11 and Table 3) showed a significant (0.5-
fold) decrease in the Vmax value of the APLT enzyme without any significant change in 
the Km value. Like other experiments, these were repeated three times for statistical 
analysis.  
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Figure 11: Transient expression of the Atp8a1-D409K phosphorylation site mutant 
causes an inhibition of Vmax without any significant change in Km for the APLT 
activity in the N18 cells. (a) The Atp8a1-D409K-pcDNA6/myc-His transfected N18 
cells showed immunostaining with a Myc Ab. (c) and (d) Lineweaver-Burk analysis 
showed that expression of Atp8a1-D409K in N18 cells elicits a decrease in Vmax 
without affecting the Km value for plasma membrane APLT. 
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(Paired t-test was used for data analysis because, in each experiment, aliquots of the same batch of cells were transfected with 
the two vectors) 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Atp8a1-D409K expression causes a decrease in Vmax value of the APLT activity of the plasma membrane of N18 
cells. 
Exp. Empty Vector in N18 Atp8a1-D409K in N18 
Fold Increase in Vmax in 
presence of Atp8a1-D409K 
 Km (µM) 
Km(µM) Mean± 
Std.Dev. 
Vmax 
(molecules/ 
min/cell) Km (µM) 
Km(µM) Mean± 
Std.Dev. 
Vmax 
(molecules/ 
min/cell) 
Fold 
Increase Mean± Std.Dev 
1 0.077  6.3x104 0.062  3.2x104 0.508  
2 0.089 0.105±0.04 7.4x104 0.085 0.074±0.012 4x104 0.581 0.55±0.037 
3 0.150  3.6x104 0.074 P=0.2929 2.0x104 0.556 P=0.0351 
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3.5 Expression of phosphorylation site mutants of Atp8a1 in N18 cells leads to PS 
externalization:  
 To further establish that Atp8a1 is the plasma membrane APLT in N18 cells, 
maintaining the asymmetric distribution of phosphatisylserine, we assayed PS 
externalization. If Atp8a1 is the PM-APLT of N18 cells, then suppression of its activity 
by overexpression of phosphorylation site mutants should lead to an increase in PS 
externalization.  
 In this study, N18 cells were transiently transfected with vectors expressing 
Atp8a1 mutants and analyzed by the standard surface-labeling assay using 
Alexafluor488-coupled annexin V (annexin V binds specifically to externalized PS). The 
results showed that expression of the Atp8a1 mutants, but not sense Atp8a1 or the empty 
vector, caused pronounced PS externalization in these cells. Transfection efficiency was 
confirmed by co-transfection with a pAsRed2-N1vector, which expresses the red 
fluorescent protein AsRed2, and the number of PS-exposed cells was normalized to the 
number of transfected cells for quantification and statistical analysis (Figure 12).  
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Figure 12:  Transient expression of Atp8a1 mutants causes externalization of PS in 
the N18 cells. (a) Transfection of the mutants of Atp8a1 causes PS externalization as 
shown by staining with annexin V-Alexafluor488 (Green)  (Annexin V binds to PS).    
Co-transfection of the pAsRed2-N1 vector (Red) differentiates the transfected cells from 
the non-transfected. Pictures shown are representative of two experiments, each 
performed with triplicate wells of N18 cells. (b) Enlarged pictures show outer leaflet 
plasma membrane annexin staining in the mutant Atp8a1-expressing cells as compared to 
empty vector-transfected or sense, wild type Atp8a1-expressing cells.  (c) The number of 
annexin V-stained cells was normalized to the total number of transfected cells/well and 
the values used for statistical analysis using paired t-test.   
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 (a)                                    Expression of Atp8a1 phosphorylation site-mutants leads to PS externalization 
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Figure 12: (continued) 
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3.6 Transient overexpression of Atp8a2 causes a decrease in both Km and Vmax 
values of the plasma membrane APLT in the mouse neuroblastoma cell line N18: 
 So far, our data indicates that Atp8a1 is the plasma membrane APLT in N18 cells. 
However, to demonstrate that these changes observed were not an artifact of transfection 
that would result from expression of any Type-IV P-type ATPase, we transiently 
overexpressed Atp8a2 and determined the Km and Vmax values. Overexpression of 
Atp8a2 in N18 cells was confirmed by western blot analysis using the Atp8a2 antibody 
(ATPase IB ab) and by immunocytochemistry using a Myc-antibody.  In contrast to our 
previous observations with Atp8a1, overexpression of Atp8a2 caused a decrease in both 
Vmax and Km values (Figure 13). These results confirmed that indeed overexpression of 
Atp8a1 in N18 cells produces a specific increase in the plasma membrane NBD-PS 
translocation.  The decreased observed in the presence of overexpressed Atp8a2 could be 
due to a non-specific effect exerted by this molecule on the endogenous plasma 
membrane APLT. 
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Figure 13: Unlike Atp8a1, Atp8a2, causes a decrease in Vmax and Km for NBD-
PS translocation in N18 cells. (a) Immunoblotting using an Atp8a2 antibody shows a 
significant increase in Atp8a2 expression in Atp8a2-pcDNA6.1/myc-His C transfected 
cells (paired t-test, n=3). (b) The Atp8a2-pcDNA6.1/myc-His-transfected N18 cells 
showed immunostaining with a Myc Ab, but the empty vector-transfected cells showed 
no staining. (c) The substrate saturation curves indicate no increase in Vmax in the 
Atp8a2 overexpressing cells. (d) & (e) Lineweaver-Burk analysis showed that 
overexpression of Atp8a2 in N18 cells changes both Vmax and Km.  
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Plasma membrane APLT kinetics in N18 cells overexpressing Atp8a2
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(Paired t-test was used for data analysis) 
 
 
 
 
  
 
 
 
 
Table 4: Atp8a2 overexpression causes a decrease in Vmax value of the APLT activity of the plasma membrane of N18 cells. 
Exp. Empty Vector in N18 Atp8a2 in N18 
Fold Increase in Vmax in 
presence of Atp8a2 
 Km (µM) 
Km(µM) Mean± 
Std.Dev. 
Vmax (molecules/ 
min/cell) Km (µM) 
Km(µM) Mean± 
Std.Dev. 
Vmax 
(molecules/ 
min/cell) Fold Increase Mean± Std.Dev 
1 0.041  6.3x104 0.007  3.2x104 0.508  
2 0.063 0.045±0.02 4.0x104 0.01 0.01±0.005 2.9x104 0.725 0.58±0.12 
3 0.032  8.4x104 0.016 P=0.08464 4.3x104 0.512 P=0.0884 
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3.7 PS externalization in the Dentate Gyrus of Atp8a1 (-/-) mice:  
           We have shown that Atp8a1 is the plasma membrane APLT in the mouse 
neuroblastoma cell-line N18, and that its suppression leads to an increase in PS 
externalization. However, to better understand the physiological importance of Atp8a1 
and the consequence of its elimination in neuronal cells, deletion of the gene for Atp8a1 
in mice was needed. An Atp8a1 (-/-) mouse line has been prepared and characterized by 
Deltagen, Inc. For our studies, we obtained the Atp8a1 (+/-) mice commercially from 
JAX lab and paired them to obtain the Atp8a1 (-/-) mice. Genotyping of these mice was 
performed as described in materials and methods. As reported by Deltagen, the Atp8a1 (-
/-) mice have no abnormal phenotypic characteristics.  
           We wanted to test a hypothesis that came into view after confirming that Atp8a1 
was the plasma membrane APLT in the neuroblastoma cell line, but not in the 
differentiated hippocampal derived cell line.  We hypothesized that Atp8a1 could be the 
plasma membrane APLT of fast dividing neuronal cells. As it is known, the dentate gyrus 
(DG) is one of the few regions of the adult brain where neurogenesis takes place. 
Neurogenesis has been shown to play an important role in the formation of new 
memories (Kee 2007).  Thus, we examined PS externalization by annexin V staining in 
dissociated cells from the DG and hippocampal culture slices of Atp8a1 (-/-) and wild 
type mice. The results showed a striking increase in PS externalization in the Atp8a1 (-/-) 
mice over that in the wild type mice (Figure 14 and 15), thus confirming our hypothesis.  
           As stated above, the DG plays an important role in memory formation. Also, 
elimination of Atp8a1 expression leading to PS externalization in the proliferating cells 
of the DG may result in phagocytosis of the PS-exposed neuronal cells, as previously 
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observed in C. elegans germ cells (Darland-Ransom 2008a). Even during late 
embryogenesis, many proliferating neural cells present in the hippocampus of the Atp8a1 
(-/-) mice may be eliminated by phagocytosis. Thus, we expected a loss of hippocampal 
neurons, which may contribute to behavioral deficits. The Atp8a1 (-/-) mice were 
subjected to behavioral analysis by using the water T-maze, which is currently used to 
evaluate learning and memory abilities in knockout mice. The results obtained indicated 
that the Atp8a1 (-/-) mice suffer from delayed hippocampal learning as compared to the 
wild type mice (Figure 16).  
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Figure 14: PS-externalization in cells from the dentate gyrus of Atp8a1 (-/-) mice but 
not wild type mice.  (a) Cells from the DG were isolated from hippocampal slices of 
control and Atp8a1 (-/-) mice. Briefly, the DG was isolated using a 1.5-mm bore tissue 
puncher. Cells were gently dissociated and treated with Alexafluor 488-annexin V to 
monitor externalized PS, followed by propidium iodide (PI) treatment to detect apoptosis. 
(b) Enlarged pictures showing strongly stained annexin V (+) cells in the Atp8a1 (-/-) 
mice as compared to the wild type mice. (c) Annexin V stained cells (green) co-localized 
with Hoechst stained cells (Blue). (d) The number of annexin V stained cells was 
normalized to the total number of cells from two different mice and the values used for 
statistical analysis unpaired t-test.  
  
63 
PS externalization in dissociated cells from the DG of Atp8a1 (-/-) mice 
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Figure 14: (Continued) 
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Figure 15: PS externalization observed in the DG of the Atp8a1 (-/-) mice, but not the wild type mice. Cultured hippocampal 
slices (400 µm) were treated with Alexafluor 488-annexin V to monitor externalized PS, followed by propidium iodide (PI) treatment 
to detect apoptosis. (a) Images (100x) were obtained by confocal microscopy.  (b) Statistical analysis was performed using “Image J”-
scans of all data from two experiments.   
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Figure 16:  Atp8a1 (-/-) mice display a marked delay in hippocampal-dependent 
learning.  The wild type and Atp8a1 (-/-) mice were tested for hippocampal function 
using the water T-maze protocol.  Results were from two sets of experiments, each 
performed with four mice in each of the two groups (Wild type and Atp8a1-/-).  No 
dramatic sex difference was observed.  Mice consistently committing two or less errors 
on two consecutive days were considered to have reached the criterion.  *For both males 
and females Atp8a1 (-/-) vs. wild type p< 0.014. (V. Punia, P. Banerjee, unpublished 
data) 
* 
* 
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CHAPTER 4 
DISCUSSION 
 
           Apoptosis or programmed cell death is an important event that occurs throughout 
the life span of an organism. During development, apoptosis is as essential as mitosis. For 
example, during the formation of fingers and toes of a fetus, removal of the tissue 
between them by apoptosis is needed. Also, the nervous system produces excess neurons, 
and only those neurons that are capable of forming proper synapses survive. The rest are 
eliminated by apoptosis. In homeostasis, apoptosis helps maintain a constant number of 
cells constant by balancing with mitosis.  
           Apoptosis is a clean process that eliminates unwanted cells avoiding the 
inflammatory problems of necrosis. Thus, it is the perfect process that can be used for 
eliminating cancer cells. Chemotherapy has been shown to function through the apoptotic 
pathway (Fisher 1994). There has been progress in understanding the events underlying 
drug-induced apoptosis. Several researchers have shown the involvement of caspases, 
especially caspase-8 and 9 (Sun 1999, Budihardjo 1999, Ferreira 2000). Chemotherapy is 
very effective in eliminating cancer cells, but it also adversely affects normal cells. In our 
quest to target brain cancer cells specifically without affecting normal cells, we first 
studied the current literature to understand how our immune system (phagocytes) 
differentiates between apoptotic and normal cells.  
The well-known characteristic of the apoptotic cells is the presence of PS in the 
outer leaflet of the plasma membrane. In normal cells, PS remains in the inner leaflet and 
this asymmetric distribution of PS is maintained by plasma membrane 
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aminophospholipid translocases (APLTs), also known as flippases. The pathway by 
which PS is externalized during apoptosis is still unknown. A group of researchers have 
shown that cytochrome c released from the mitochondria oxidizes PS (present in the 
inner leaflet). They speculate that oxidized PS affects its recognition by APLTs, thus 
resulting in an inhibition of its activity. Consequently, PS remains in the outer leaflet of 
the plasma membrane where it gets recognized by PS receptor-bearing phagocytes 
(Kagan 2000, Tyurina 2000) (Figure 17).  
           The role of plasma membrane APLTs in maintaining PS asymmetry in the plasma 
membrane is crucial and inhibition of PM-APLTs could lead to PS exposure and 
phagocytosis of a cell. This is why we have tried to identify the protein or proteins 
responsible for the plasma membrane APLT activity in neuronal cells. Identification of 
this protein will help in our quest to target brain cancer cells. Our approach is to inhibit 
the APLT activity in brain cancer cells specifically, thus leading to their removal by the 
clean process phagocytosis.  
           As mentioned in the introduction, a well-known candidate for the plasma 
membrane APLT has been Atp8a1, which belongs to the Type IV subfamily of P-type 
ATPases. Atp8a1was purified (Moriyama 1988), and its cDNA was cloned (Tang 1996) 
from bovine chromaffin granules. Drs2, the Atp8a1 yeast homolog, is the founding 
member of the Type-IV subfamily of P-type ATPases, whereas the other members are 
putative APLTs (Ripmaster 1993, Tang 1996). Studies showed that a yeast strain (Δdrs2) 
lacking the Drs2 protein was unable to internalize NBD-PS (Tang 1996). Also, recently 
Darland-Ransom et al (Darland-Ransom 2008a) showed that the Atp8a1 C. elegans 
homolog (TAT-1) maintains PS in the inner leaflet of plasma membrane. However, there 
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is still controversy regarding the identification of the plasma membrane APLT and 
whether Atp8a1 functions in the plasma membrane or in intracellular organelles. For 
example, Graham’s laboratory showed that Drs2p was localized to the yeast Golgi 
network rather than in the plasma membrane (Chen 1999, Devaux 2006). Also, recently 
in vitro analysis of the purified protein showed that Atp8a1 was similar to, but not the 
same as, the plasma membrane APLT (Paterson 2006).  Finally, Züllig and coworkers 
reported that RNAi-mediated suppression of TAT-1 causes stimulation (rather than 
inhibition) of plasma membrane APLT activity, but, as stated above, Darland-Ransom 
and coworkers showed just the opposite effect.  
           Up to date there has been no report involving Atp8a1 as the plasma membrane 
APLT of neuronal or neurotumor cells. Here, we demonstrate that Atp8a1 is the plasma 
membrane APLT of the neuroblastoma cell line N18.  
           Interestingly, Atp8a1 APLT activity appears to be cell-type specific. In our 
studies, we tested two cell lines: a mouse neuroblastoma cell line (N18) and a 
hippocampal derived cell line (HN2). By searching through literature and analyzing 
different protocols, we put together a modified plasma membrane APLT assay. In this 
assay, as described in materials and methods, we are able to record changes in plasma 
membrane APLT activity by measuring the increase or decrease in fluorescence of NBD-
PS present in the inner leaflet of the plasma membrane. The plasma membrane APLT 
activity is initiated at 28 °C (at which no endocytosis occurs). In Figure 8, we are able to 
visualize the internalization of NBD-PS to the inner leaflet of the plasma membrane as 
the incubation at 28 °C proceeds up to 10 min. The ability to measure only NBD-PS in 
the inner leaflet of the plasma membrane in this assay is made possible by the addition of 
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sodium dithionite after incubation at 28 °C.  Sodium dithionite removes fluorescence 
from the outer leaflet (untranslocated NBD-PS) by reducing NBD-PS to ABD-PS (a non-
fluorescent phospholipid) (Figure 7).   
 In our first set of experiments, we analyzed the effect of transient overexpression of 
Atp8a1 in the PM-APLT of the two cell lines (N18 and HN2) through a time-course 
APLT assay. These two cell lines were used because, as stated above, we wanted to 
identify the plasma membrane APLT of neuronal (differentiated HN2) and neurotumor 
(N18) cells. The results (Figure 9) obtained from these experiments showed that 
overexpression of Atp8a1 in N18 cells cause an increase in the plasma membrane APLT 
activity. However, this was not the case for the HN2 cells.  Overexpression of Atp8a1 in 
differentiated HN2 caused a decrease in the plasma APLT.  This led us to conclude that 
Atp8a1 was the plasma membrane APLT in N18 cells and thus hypothesizing that 
Atp8a1 could be the plasma membrane APLT of neurotumor cells and/or fast dividing 
cells.  
           To further support our results that Atp8a1 was the plasma membrane APLT of the 
N18 cells, we turned to enzyme kinetics. The kinetic parameters, Km and Vmax, helps in 
determining if the overexpressed enzyme is identical to the endogenous enzyme 
catalyzing a specific reaction. If Atp8a1 were indeed the plasma membrane APLT 
enzyme in N18 cells, then overexpression of this molecule would cause an increase in the 
Vmax value due to an increase in the number of the endogenous APLT molecules 
catalyzing the translocation of NBD-PS. Also, if Atp8a1 is identical to the endogenous 
PM-APLT, its overexpression or suppression should not change the Km value of PM-
APLT. Thus, in our next experiments, we performed substrate concentration-dependant 
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APLT assays (as described in materials and methods). Km and Vmax values were 
calculated by graphing a Lineweaver-Burk plot. As expected and confirming our 
hypothesis, transient overexpression of Atp8a1 in N18 cells cause an increase in the 
Vmax value without affecting the Km value of the plasma membrane APLT activity 
(Figure 10 and table 2).  
           If overexpression of Atp8a1 causes an increase in the plasma membrane APLT 
activity of N18 cells as evidenced by an increase in Vmax, then suppression of Atp8a1 
activity should lead to a decrease in the plasma membrane APLT activity and a decrease 
in the Vmax value. As expected, this was what we observed in the following 
experiments.  
           To suppress the activity of Atp8a1, we created phosphorylation-site mutants. In 
these mutants, the ability to hydrolyze ATP and translocate PS is hampered by a mutation 
in the aspartic acid residue of the P-type signature sequence. We believe that these 
phosphorylation-site mutants could be acting as possible dominant negative mutants, 
suppressing the activity of the wild-type Atp8a1. When we expressed the Atp8a1 
phosphorylation-site mutants and measured the Km and Vmax values, we observed, as 
expected, a decrease in the Vmax value but no significant change in the Km value (Figure 
11 and table 3). The concept of dominant negative mutations as a tool to study the 
function of specific genes was first introduced by Herskowitz in 1987 (Herskowitz 1987). 
Dominant negative mutants are capable of competing with the wild-type enzyme for its 
substrate. They can efficiently inhibit any functional consequence of the wild type 
enzyme if, and only if the enzymatic reaction is limited by the concentration of a protein 
that critically regulates the processing or activation of the enzyme. We postulate that the 
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limiting protein for which our Atp8a1 phosphorylation-site mutants compete with the 
wild-type Atp8a1is a chaperone-like protein such as CDC50. Studies have shown that the 
interaction between CDC50 and the Atp8a1 homolog, Atp8b1, is required for the release 
of this Type IV P-type ATPase from the endoplasmic reticulum (ER) and targeting to the 
plasma membrane (Paulusma 2008). CDC50 is a glycosylated protein (of approximately 
60 kDa) and its importance in targeting Type IV P-type ATPases to the plasma 
membrane was first shown in yeast by Saito et al (Saito 2004). A mammalian homolog of 
CDC50 could be the chaperone binding to the Atp8a1 phosphorylation-site mutants, 
which could prevent the targeting of the wild-type Atp8a1 to the plasma membrane, and 
thereby inhibiting Atp8a1-catalyzed translocation of phosphatidylserine to the inner 
leaflet of the plasma membrane.  
           If indeed Atp8a1 is the plasma membrane APLT in N18 cells, then suppression of 
Atp8a1 by overexpression of the Atp8a1 phosphorylation-site mutants should lead to PS 
externalization. This is exactly what we observed when we measured PS externalization 
through the annexin V staining assay. Only cells with externalized PS will stain with 
annexin V, which was tagged with Alexa fluor 488. Expression of the two Atp8a1 
mutants (Atp8a1-D409K and Atp8a1-D409E) caused an increase in annexin V staining in 
the N18 cells (Figure 12).  
           The suppression of Atp8a1 activity observed through the substrate-dependent PM-
APLT assays and the annexin V staining assays was not 100%.  This could be due to 
transient expression, which is at the most 80% efficient. However, another possibility 
could be that Atp8a1 is not be the only protein responsible for the plasma membrane 
APLT activity in N18 cells. To address this question, we decided to overexpress another 
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Type IV P-type ATPase, Atp8a2. We chose Atp8a2 because it is the closest paralog of 
Atp8a1. When we transiently overexpressed Atp8a2 in N18 cells, the plasma membrane 
APLT activity decreased. Results showed a decrease in both Vmax and Km values, 
signifying that Atp8a2 is not the plasma membrane APLT in these cells (displaying a 
different Km value) (Figure 13 and table 4). From this set of experiments we can also 
confirm that the increase in Vmax observed with the overexpression of Atp8a1 was not 
an artifact of transfection.  
           Together these results support our hypothesis that Atp8a1 is the plasma membrane 
APLT in N18 cells. We further hypothesized that Atp8a1 could be the plasma membrane 
APLT of fast-dividing neuroblasts. To test this postulate, we performed some preliminary 
experiments using an Atp8a1 (-/-) mouse strain.  
           It has become well accepted that neurogenesis (cell proliferation) occurs in the 
dentate gyrus (DG) of the hippocampus, a region important in memory and learning 
function.  Thus, for our purpose of testing the hypothesis that Atp8a1 could be the plasma 
membrane APLT of fast dividing neuroblasts, we decided to focus our attention in the 
proliferating cells of the DG. To better understand the physiological importance of 
Atp8a1 and the consequence of its elimination in the fast diving neuroblasts of the DG, 
we used the Atp8a1 (-/-) mice, which were obtained by pairing Atp8a1 (+/-) from JAX 
lab.  These mice did not have any reported, abnormal phenotypic characteristics. 
However, when we examined the asymmetric distribution of PS in the proliferating 
neuroblasts of the DG, we observed that many of those cells harbored exposed PS in the 
outer leaflet of the plasma membrane. We monitored PS externalization by annexin V 
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staining in dissociated cells from the DG and hippocampal culture slices of Atp8a1 (-/-) 
and wild type mice (Figure 14 and 15).  
           As mentioned previously, PS acts as a marker for phagocyte recognition when 
present in the outer leaflet of the plasma membrane. Thus, if Atp8a1 is the plasma 
membrane APLT of proliferating neuroblasts in the DG, then its absence in the Atp8a1 (-
/-) mice leading to PS externalization, as observed in our results, should result in 
phagocytosis.  Consequently, we could expect a loss of hippocampal neurons, which 
could contribute to impairment of learning and memory. To test this hypothesis, The 
Atp8a1 (-/-) mice were subjected to behavioral analysis by using the water T-maze. 
According to the results obtained, the Atp8a1 (-/-) mice appeared to suffer from delayed 
hippocampal learning as compared to the wild type mice (Figure 16). However, not all 
visual-based learning tests are hippocampal-dependant. To confirm that indeed 
elimination of Atp8a1 affects hippocampal functioning, a test such as the T-maze non-
matching-to-place task will be used in our future studies. In this test, the spatial working 
memory is tested and impairments in the septo-hippocampal system are measured. 
Briefly, in the T-maze non-matching-to-place task, each trial consisted of a sample run 
and a choice run. On the sample run mice are forced either left or right by a wooden block 
to obtain a milk reward, according to a pseudorandom sequence in which equal numbers 
of left and right turns are done per session, and with no more than three consecutive turns 
in same direction. The block is then removed and mice are allowed a free choice of either 
arm. The time interval between the sample run and the choice run is about 15 sec. The 
mouse is rewarded for choosing the previously unvisited arm (i.e., for alternating) (Reisel 
et al. 2002). 
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           Our studies presented here strong evidence indicating that Atp8a1 is the plasma 
membrane APLT of the neuroblastoma cell line N18, and most likely the plasma 
membrane APLT of the proliferating neuroblasts of the DG. Thus, this protein could play 
a serious role in the maintenance of normal hippocampal function.  Our findings also 
open a new strategy for eliminating brain cancer cells by specifically suppressing Atp8a1 
activity in neurotumor cells, which would cause their elimination through phagocytosis 
without affecting normal cells.  
 
Figure 17: Proposed pathways by which PS is externalized during apoptosis. 
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